Details of the Drug

General Information of Drug (ID: DMXYGG3)

Drug Name

RP2-001-18

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Oncolytic virus therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04336241) Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors. U.S. National Institutes of Health.